Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 10 recruiting now later-stage tilt

Colorectal Cancer Screening: later-stage trial registry

10 of 20 indexed Colorectal Cancer Screening trials are currently recruiting, with more weight in Phase 3-4.

Corpus placement: #848 of 28,707 conditions by registered trial count.

20 US clinical trials · 10 currently recruiting · #848 of 28,707 conditions by registered trial count

Colorectal Cancer Screening: 20 US clinical trials tracked, 10 recruiting.

Colorectal Cancer Screening is the subject of 20 registered US clinical trials on ClinicalTrials.gov, 10 of them currently open to new participants. 2 are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most active sponsor is Massachusetts General Hospital, running 3 of these trials.

Enrollment posture brief

Registry condition colorectal-cancer-screening

OPEN 10 | RECR 50% | LATE 2 | EARLY 0 | RANK #848 | SPON 3

Nearest open-share peer: Abdominal Aortic Aneurysms (50% recruiting · 6 trials)

Advanced or Metastatic Solid55%ALS50%Colorectal Cancer Screen (th…50%Abdominal Pain25%Acute Myocardial Infarction25%
Open-enrollment share among volume-matched conditions near Colorectal Cancer Screening

Colorectal Cancer Screening lists 10 open slots (50% of 20 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Colorectal Cancer Screening on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Colorectal Cancer Screening is recruiting above its size-band peers.

    10 of 20 indexed trials (50%) are open to enrollment, against a 39.7% average across 762 conditions with 20-99 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates Colorectal Cancer Screening research.

    Massachusetts General Hospital accounts for 3 of 20 trials (15%). 18 distinct sponsors appear on at least one study for this condition label.

  3. Typical Colorectal Cancer Screening enrolment sits around 728 participants.

    Median target enrolment is 728 among the 20 trials that report a genuine target (sentinel values excluded). 5 of those (25%) plan for fewer than 100 participants.

  4. Colorectal Cancer Screening splits between interventional and observational designs.

    13 interventional and 7 observational studies make up this index (65% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 31Phase 41

Open and recent trials

20 total, page 1 of 1

RECRUITING NA 80,000 participants

Use of a Colorectal Cancer Screening Decision Support Tool in Primary Care

Massachusetts General Hospital

NCT06625983

RECRUITING NA 6,500 participants

Effectiveness of a Cloud-based Digital Health Navigation Program for Colorectal Cancer Screening

Digital Health Navigation Solutions

NCT06821009

RECRUITING 5,000 participants

Prospective Collection of Samples to Enable the Development of Natera Screening Assay for Early Cancer Detection

Natera

NCT06620627

RECRUITING 2,700 participants

Pilot Study for Colorectal Cancer and Advanced Adenoma Detection With the Mainz Biomed Colorectal Cancer Test

Mainz Biomed

NCT06864338

RECRUITING 1,000 participants

A Noninvasive and Screening miRNA Signature for Gastrointestinal Cancer

City of Hope Medical Center

NCT07224750

RECRUITING NA 350 participants

Multilevel Action Toward Colorectal Cancer and Hepatitis C Education and Screening

H. Lee Moffitt Cancer Center and Research Institute

NCT06745895

RECRUITING Phase 4 300 participants

Cleansing Options in Out-Patient Setting to Improve Tolerance (COOP SIT) Trial

Morehouse School of Medicine

NCT07215000

RECRUITING NA 184 participants

Impact of Protect Your Colon™ on CRC Screening

Cedars-Sinai Medical Center

NCT05929820

RECRUITING 45 participants

Positive Fit to Colonoscopy: Closing the Gap

Massachusetts General Hospital

NCT06763432

RECRUITING 40 participants

CRC Screening in Unscreened Individuals 45-54

Massachusetts General Hospital

NCT06757192

COMPLETED NA 7,465 participants

FLU-FIT Program at Kaiser Permanente Northern California

University of California, San Francisco

NCT01210235

COMPLETED NA 3,880 participants

Effect of Patient Portal Messaging Before Mailing Fecal Immunochemical Testing Kit on Colorectal Cancer Screening Rates

University of California, Los Angeles

NCT05115916

COMPLETED 2,404 participants

A Study of Cologuard™ in an Average Risk Population Assessing a Three Year Test Interval

Exact Sciences Corporation

NCT02419716

COMPLETED NA 802 participants

Collaborative Care to Reduce Depression and Increase Cancer Screening Among Low-Income Urban Women

Clinical Directors Network

NCT02273206

COMPLETED NA 728 participants

Information With or Without Numbers For Optimizing Reasoning About Medical Decisions

Indiana University

NCT02477553

COMPLETED NA 115 participants

Test Up Now Education Program

Florida A&M University

NCT04304001

COMPLETED Phase 3 100 participants

Study of Using Computerized Education to Increase Patients' Confidence in Their Ability to Be Screened for Colon Cancer

University of California, Davis

NCT00273585

COMPLETED 76 participants

Doctor-Patient Communication About Colorectal Cancer Screening

Memorial Sloan Kettering Cancer Center

NCT01534923

COMPLETED NA 48 participants

Multilevel Intervention Based on Colorectal Cancer (CRC) and Cervical Cancer Self-screening in Rural, Segregated Areas

Milton S. Hershey Medical Center

NCT04471194

COMPLETED NA 37 participants

Cancer Screening; Access; Awareness; Navigation

University of Illinois at Chicago

NCT04131946

Phase Distribution

PhaseTrial count
Phase 3 1
Phase 4 1

Named interventions

Most-linked intervention names on Colorectal Cancer Screening records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Community-Based (Intervention Arm) Other
1 trials
FLU-FIT Program Behavioral
1 trials
DA - Verbal Behavioral
1 trials
DA - Quantitative Behavioral
1 trials
MyChart Priming Message Behavioral
1 trials
Prevention Care Management for Cancer Screening Behavioral
1 trials
Prevention Care Management for Depression and Cancer Screening Behavioral
1 trials
Fecal occult blood test Diagnostic test
1 trials

US sites by state

Facility locations filed on Colorectal Cancer Screening trials. A trial with sites in several states counts in each.

California 6 trials
Massachusetts 3 trials
Florida 3 trials
New York 2 trials
North Carolina 2 trials
Georgia 2 trials
Texas 1 trials
Pennsylvania 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Colorectal Cancer Screening page

20 registered trials, 10 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Colorectal Cancer Screening condition card totals 20 registered trials; most-linked intervention Community-Based (Intervention Arm); top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.